Company News: Merck (MRK) issued FY15 EPS guidance above consensus

Market news

28 July 2015

Company News: Merck (MRK) issued FY15 EPS guidance above consensus

Company reported Q2 profit of $0.86 per share versus $0.81 consensus. Revenues fell 10.5% year/year to $9.79 bln versus $9.80 bln consensus.

Company issued guidance for FY15, sees EPS of $3.45-3.55 versus $3.44 consensus and revenues of $38.6-39.8 bln verdus $39.7 bln consensus.

MRK fell to $56.80 (-0.33%) on the premarket.

Company News: DuPont (DD) missed expectation

Company News: Pfizer (PFE) reported better than expected EPS and revenue

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.